Antitope and Eden Biodesign Enter Into a Research Agreement
2/6/2013 10:35:26 AM
More...
|
Eden Biodesign Assists Momotaro-Gene, Inc. to Commence Human Clinical Trials Less Than 12 Months After Being Engaged to Produce a Recombinant Adenovirus Vector from a New Cell Line
7/14/2010 10:35:33 AM
More...
|
Eden Biodesign to offer Millipore Corporation (MIL)'s Proprietary Expression Technology as part of its Cell Line Development Services and cGMP Manufacturing of Highly Productive Mammalian Cell Lines
3/24/2010 9:05:08 AM
More...
|
Watson Pharmaceuticals, Inc. (WPI) Completes Acquisition of Eden Biodesign
1/29/2010 10:52:33 AM
More...
|
Sustained Growth at Eden Biodesign Results in the Posting of 18 New Job Openings
10/27/2009 9:34:31 AM
More...
|
Eden Biodesign's U.S. Technical Director to Present at the World Vaccine Congress in Lyon, France, October 7
9/29/2009 11:21:01 AM
More...
|
Omnio Healer AB Selects Eden Biodesign for cGMP Production of its Candidate Wound Healing and Anti-Infection Treatments
8/7/2009 8:53:48 AM
More...
|
Eden Biodesign Selected by Omnio Healer AB for cGMP Production of Clinical Trial Product in Wound Healing and Anti-infection
8/6/2009 8:35:32 AM
More...
|
Eden Biodesign and Selexis SA Announce Continued Cooperation and a Global Joint-Marketing Collaboration
6/17/2009 10:44:20 AM
More...
|